-
2201por Wu, Ming-Sian, Wang, Chun-Hsiang, Tseng, Fan-Chen, Yang, Hsuan-Ju, Lo, Yin-Chiu, Kuo, Yi-Ping, Tsai, De-Jiun, Tsai, Wan-Ting, Yu, Guann-Yi“…METHODS: Hepatic tumor samples from both hepatitis C virus (HCV) positive and negative patients (without HBV and HCV, NBNC) were examined with quantitative PCR and immunohistochemistry staining for inflammatory cytokine genes expression. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2202“…BACKGROUND: Hepatitis C virus (HCV) morbidity appears to be high in Mongolia. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2203por Kayesh, Mohammad Enamul Hoque, Ezzikouri, Sayeh, Sanada, Takahiro, Chi, Haiying, Hayashi, Yukiko, Rebbani, Khadija, Kitab, Bouchra, Matsuu, Aya, Miyoshi, Noriaki, Hishima, Tsunekazu, Kohara, Michinori, Tsukiyama-Kohara, Kyoko“…Hepatitis C virus (HCV) is a leading cause of chronic liver disease, cirrhosis, and hepatocellular carcinoma. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2204por Soto-Ramirez, Luis EnriqueEnlace del recurso
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2205
-
2206por Marques, Susana, Carmo, Joana, Túlio, Maria Ana, Bispo, Miguel, Matos, Leopoldo, Chagas, Cristina“…BACKGROUND AND AIMS: Since liver fibrosis index (LFI) was developed by Fujimoto et al., real-time elastography (RTE) has become a promising non-invasive technique to assess fibrosis in chronic hepatitis C (CHC). The aims of this study were to compare the diagnostic performance of RTE versus laboratory tests to predict advanced fibrosis (METAVIR scoring system: F ≥ 3) in patients with CHC, using liver biopsy (LB) as the reference standard; and to evaluated the impact of patient anthropometric features on RTE histogram acquisition. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2207por Cano, Ainara, Mariño, Zoe, Millet, Oscar, Martínez-Arranz, Ibon, Navasa, Miquel, Falcón-Pérez, Juan Manuel, Pérez-Cormenzana, Miriam, Caballería, Joan, Embade, Nieves, Forns, Xavier, Bosch, Jaume, Castro, Azucena, Mato, José María“…Liver fibrosis must be evaluated in patients with hepatitis C virus (HCV) after liver transplantation because its severity affects their prognosis and the recurrence of HCV. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2208“…OBJECTIVES: The Our Youth Our Response (OYOR) study explored the scope and accessibility of existing youth-oriented human immunodeficiency virus (HIV) and Hepatitis C (HCV) prevention in Atlantic Canada. METHODS: A cross-provincial, qualitative population health and gender-based analytic approach was used in this study. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2209“…Background In 2012, the Centers for Disease Control and Prevention (CDC) published guidelines supporting one-time screening for hepatitis C (HCV) in all persons born between 1945 and 1965. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2210por Feng, H‐P, Vaddady, P, Guo, Z, Liu, F, Panebianco, D, Levine, V, Caro, L, Butterton, JR, Iwamoto, M, Yeh, WW“…Use of agents to suppress gastric acid secretion is common among patients with hepatitis C virus (HCV) infection. The aims of this open‐label, three‐period, fixed‐sequence study were to evaluate the effect of famotidine and pantoprazole on the pharmacokinetics and safety of elbasvir/grazoprevir fixed‐dose combination (FDC) in 16 healthy subjects. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2211por Zhang, Shu-Ting, Shi, Ming, Shao, Lin-Nan, Zhou, Shi-Hang, Yu, Wei-Jian, Chen, Mei, Xiao, Nan, Duan, Ying, Pan, Ling-Zi, Wang, Ni, Song, Wen-Qian, Xia, Yue-Xin, Zhang, Li, Qi, Ning, Liu, Ming“…BACKGROUND: Hepatitis C virus has infected 130 to 150 million individuals globally. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2212por Awali, Reda, Lohia, Prateek, Veltman, Jennifer, Cohn, Jonathan, Crane, Lawrence R“…BACKGROUND: The newly introduced direct-acting antivirals (DAAs) for chronic hepatitis C virus (HCV) infection have substantially higher cure rates and less side effects compared with previous regimens. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2213por Economides, Minas, Hosry, Jeff, Angelidakis, Georgios, Kaseb, Ahmed, Torres, Harrys“…BACKGROUND: Hepatitis C virus (HCV)-infected patients with hepatocellular carcinoma (HCC) are at high risk for direct-acting antiviral (DAA) failure and controversy exists on the increased risk of HCC recurrence following DAAs. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2214por Siddique, Muhammad Shoaib, Shoaib, Sana, Saad, Alvia, Iqbal, Hamna Javed, Durrani, Noureen“…Of 201 patients, n= 131 (65.2%) chronic hepatitis C, compensated cirrhosis n= 47(23.4%), and with decompensated cirrhosis n=23(11.4%). …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2215por Al Mahtab, Mamun, Akhter, Shamima, U Mollick, Kutub, H Uddin, Mohammad, I Khan, Sakirul, MF Akbar, Sheikh“…Prevalence of Hepatitis B Virus and Hepatitis C Virus in a Tea Garden of Bangladesh. Euroasian J Hepato-Gastroenterol 2017;7(1):107-110.…”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2216por Bawazir, Amen, AlGusheri, Fahad, Jradi, Hoda, AlBalwi, Mohammed, Abdel-Gader, Abdel-Galil“…BACKGROUND: Hepatitis C virus (HCV) genotypes and subtypes are considered an important tool for epidemiological and clinical studies and valuable markers for disease progression and response to antiviral therapy. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2217por Ivanova Reipold, Elena, Easterbrook, Philippa, Trianni, Alessandra, Panneer, Nivedha, Krakower, Douglas, Ongarello, Stefano, Roberts, Teri, Miller, Veronica, Denkinger, Claudia“…BACKGROUND: The current low access to virological testing to confirm chronic viraemic HCV infection in low- and middle-income countries (LMIC) is limiting the rollout of hepatitis C (HCV) care. Existing tests are complex, costly and require sophisticated laboratory infrastructure. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2218por Shao, Yu-Yun, Hsieh, Min-Shu, Wang, Han-Yu, Li, Yong-Shi, Lin, Hang, Hsu, Hung-Wei, Huang, Chung-Yi, Hsu, Chih-Hung, Cheng, Ann-Lii“…Increased angiogenic activity has been demonstrated in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), but the mechanism was unclear. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2219por Huang, Hailiang, Duggal, Priya, Thio, Chloe L., Latanich, Rachel, Goedert, James J., Mangia, Alessandra, Cox, Andrea L., Kirk, Gregory D., Mehta, Shruti, Aneja, Jasneet, Alric, Laurent, Donfield, Sharyne M., Cramp, Matthew E., Khakoo, Salim I., Tobler, Leslie H., Busch, Michael, Alexander, Graeme J., Rosen, Hugo R., Edlin, Brian R., Segal, Florencia P., Lauer, Georg M., Thomas, David L., Daly, Mark J., Chung, Raymond T., Kim, Arthur Y.“…Approximately three quarters of acute hepatitis C (HCV) infections evolve to a chronic state, while one quarter are spontaneously cleared. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2220por Li, Qisheng, Lowey, Brianna, Sodroski, Catherine, Krishnamurthy, Siddharth, Alao, Hawwa, Cha, Helen, Chiu, Stephan, El-Diwany, Ramy, Ghany, Marc G., Liang, T. Jake“…Cellular microRNAs (miRNAs) have been shown to regulate hepatitis C virus (HCV) replication, yet a systematic interrogation of the repertoire of miRNAs impacting HCV life cycle is lacking. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto